Safeguard Scientifics stock analysis
Want to see SFES full AI Analyst Report?
Safeguard Scientifics (SFES) Stock Price & Analysis
SFES Stock Chart & Stats
- Day’s Range
- $0.62 - $0.62
- 52-Week Range
- $0.22 - $1.89
- Previous Close
- $0.62
- Volume
- N/A
- Average Volume (3M)
- 13.94K
- Market Cap
- $10.33M
- Enterprise Value
- -$20.39T
- Total Cash (Recent Filing)
- $6.82M
- Total Debt (Recent Filing)
- $760.00K
- Price to Earnings (P/E)
- 0.5
- Beta
- -0.15
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Apr 21, 2026
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage
Low leverage provides financial flexibility and reduces risk, allowing the company to potentially invest in opportunities without the burden of high debt.
Strategic Partnerships
Strong partnerships enhance the company's ability to source and scale investments, supporting long-term growth and value creation in its portfolio.
Industry Focus
Focusing on high-growth sectors like healthcare and digital media positions the company to benefit from sector-specific trends and innovations.
Bears Say
Negative Cash Flow
Persistent negative cash flow indicates poor cash generation, which can limit the company's ability to invest in growth opportunities and meet financial obligations.
Lack Of Revenue
The absence of revenue highlights challenges in monetizing investments, which can hinder the company's ability to achieve profitability and sustain operations.
Declining Equity
Shrinking equity base may indicate underlying financial instability, reducing the company's capacity to absorb losses and invest in future growth.
Safeguard Scientifics News
SFES FAQ
What was Safeguard Scientifics’s price range in the past 12 months?
What is Safeguard Scientifics’s market cap?
When is Safeguard Scientifics’s upcoming earnings report date?
How were Safeguard Scientifics’s earnings last quarter?
Is Safeguard Scientifics overvalued?
Does Safeguard Scientifics pay dividends?
What is Safeguard Scientifics’s EPS estimate?
How many shares outstanding does Safeguard Scientifics have?
What happened to Safeguard Scientifics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Safeguard Scientifics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Safeguard Scientifics
Safeguard Scientifics, Inc., a former private equity and venture capital firm, is no longer actively seeking new investments. Historically, the firm specialized in a broad range of financing activities, including providing capital for company expansion and growth, facilitating management buyouts, executing recapitalizations, driving industry consolidations, and supporting corporate spin-offs. Their investment scope covered both early and growth-stage companies. Typically, Safeguard Scientifics participated in Series A, B, or C funding rounds, with an opportunistic approach to seed-stage investments. Their primary sector focus spanned technology, financial services, and healthcare. Within the technology sphere, their interests were diverse, encompassing areas such as software-as-a-service (SaaS), adtech, digital media, the Internet of Everything (IoE), advanced security solutions, predictive analytics, machine learning, artificial intelligence, enterprise software, technology-enabled services, internet/new media, financial technology (FinTech), cloud computing, mobile, social platforms, big data, in-memory computing, and select business services. For these tech ventures, they considered companies requiring up to $25 million in capital. In the healthcare sector, the firm directed its investments towards molecular and point-of-care diagnostics, various medical devices, regenerative medicine, broader medical technology, digital health solutions, healthcare technology, specialized pharmaceuticals, and chosen healthcare services. Geographically, Safeguard Scientifics invested across the entire United States, with a particular emphasis on the Mid-Atlantic region, and also extended its reach into Southeastern Canada. Financial commitments for growth equity financing generally ranged from $5 million to $25 million, while early-stage financings typically saw investments between $5 million and $10 million. The firm's investment strategy often targeted a variety of capital structures, including self-funded (bootstrapped) companies, corporate divisions or business units, and venture capital-backed entities seeking a growth partner. Safeguard Scientifics aimed to be the largest stakeholder in its portfolio companies, typically acquiring an ownership stake between 20% and 50%, though they were flexible and might occasionally take either a majority or a smaller interest. A strong preference existed for companies possessing proprietary technology and intellectual property. Furthermore, the firm routinely sought a Board seat in its invested companies. Founded in 1953 as Lancaster Corporation, the company adopted the name Safeguard Scientifics, Inc. in 1981. Its main office is located in Radnor, Pennsylvania, with an additional presence in Weston, Massachusetts.
- Sector
- Financial
- Industry
- Asset Management
- CEO
- Mark R. Dow
- Employees
- 33
- Website
- www.safeguardscientifics.com
- Address
- 150 North Radnor Chester Road, Radnor, PA, 19087, US
Safeguard Scientifics (SFES) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 5 | 5 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 10 | 0 | 2 |


